Filgrastim Hospira (US)
Sponsors
Pfizer
Conditions
Neutropenia (Low White Blood Cell Count)
Phase 1
A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)
CompletedNCT02766634
Start: 2016-03-31End: 2016-06-30Updated: 2016-07-21
A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)
CompletedNCT02766647
Start: 2015-12-31End: 2016-03-31Updated: 2016-05-10